(VIP) Viril-Ity-Power Tabs Recall: ED Dietary Supplement

On May 30, 2008, the FDA announced a nationwide recall for Viril-Ity Power (VIP) Tablets. The dietary supplement is sold over-the-counter for erectile dysfunction and sexual enhancement. The tablets contain an undeclared ingredient, hydroxyhomosildenafil, which is an analog of the active chemical ingredient in Viagra.

Earlier the same week, the FDA issued an alert for another dietary supplement which contained the same undeclared ingredient. The FDA requested that SEI Pharmaceuticals issue an Xiadafil VIP Tablet Recall, since the dietary supplement could interact with other medications and impact users’ blood pressure or potentially lead to fatal injuries.

The Viril-Ity-Power Tab recall applies to all lots of the 560mg/serving tablets. They are sold in 2-tablet blister packs and 8-tablet bottles. Consumers have been told to immediately stop using the supplement, since the undeclared chemical could lead to a severe lowering of blood pressure to potentially fatal levels.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Hydroxyhomosildenafil could interact with nitrates that are found in several medications, including nitroglycerin. Many prescription medications taken by individuals with diabetes, high blood pressure and heart disease could contain nitrates.

Any consumers who experience Viril-Ity-Power (VIP) Tab side effects, have been urged to seek medical attention report any adverse events which may be related to the supplement to the FDA’s MedWatch Program at 1-800-FDA-1088 or on the internet at www.fda.gov/medwatch/report.htm.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills.
A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers.